Mejora de la calidad de la especificación de la inclusión en ensayo clínico sobre prescripciones en quimioterapia

The overall frequency of prescriptions with errors decreased significantly from 9.3% to 3.5%, with an extraordinary reduction in Haematology (34.1% to 1.8%) related to the multiple myeloma trials. The corrective measures implemented have proved to be useful in CT.